Author Question: Bronchiectasis characterized by progressive, distal enlargement of the airways, resulting in ... (Read 58 times)

madam-professor

  • Hero Member
  • *****
  • Posts: 584
Bronchiectasis characterized by progressive, distal enlargement of the airways, resulting in sac-like dilatations is classified as:
 
  a. cylindrical bronchiectasis.
  b. varicose bronchiectasis.
  c. cystic bronchiectasis.
  d. obstructive bronchiectasis.

Question 2

You are called to the ER to assess a 25-year-old female patient in status asthmaticus. Her PEFR results of pre- and post-bronchodilator therapy are given below:
 
  Pre-bronchodilator Post-bronchodilator
  1st attempt 216 334
  2nd attempt 224 330
  3rd attempt 210 340
  You should suggest to the ER physician to:
  a. stop the bronchodilators.
  b. repeat the PEF measurement.
  c. increase the medication dosage.
  d. continue current therapy.



emilymalinowski12

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

ANS: C
Bronchiectasis refers to the abnormal, irreversible dilatation of the bronchi caused by destructive and inflammatory changes in the airway walls. Bronchiectasis characterized by progressive, distal enlargement of the airways, resulting in sac-like dilatations is classified as Cystic bronchiectasis.

Answer to Question 2

ANS: D
When assessing PEFR results, the highest measurement pre and post should be used to calculate the percentage improvement (pre-post/pre  100). Any improvement of 12 percentage in the PEFR or 200 ml in the FEV1 represent a significant improvement for the bronchodilator. In this case, the patient had an improvement of 52 percentage; hence the therapy should be continued.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

For a complete list of videos, visit our video library